1 min read
Xtant Medical Holdings Announces Board-Led Review as Q3 Revenue Falls
Revenue was $24.3 million, down 26.9% year over year and $1.18 million below estimates. GAAP earnings per share was a loss of $0.03, missing estimates by one cent.

Xtant Medical Holdings Inc. announced a board-led strategic review as its third-quarter revenue fell 26.9% year over year and GAAP earnings per share missed estimates.
Revenue totaled $24.3 million.
The revenue figure was $1.18 million below estimates.
GAAP earnings per share was a loss of $0.03.
That per-share result missed estimates by one cent.
The company posted a $1.5 million quarterly loss on an adjusted EBITDA basis, a non-GAAP measure.
Xtant’s board is leading the strategic review process.